{"id":"https://openalex.org/W2591567620","doi":"https://doi.org/10.1182/blood.v126.23.1913.1913","title":"Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia","display_name":"Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2591567620","doi":"https://doi.org/10.1182/blood.v126.23.1913.1913","mag":"2591567620"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1913.1913","doi":"https://doi.org/10.1182/blood.v126.23.1913.1913","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1913.1913","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067492340","display_name":"Mehrdad Hefazi","orcid":"https://orcid.org/0000-0001-8860-3380","observed_orcids":["https://orcid.org/0000-0001-8860-3380"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mehrdad Hefazi Torghabeh","raw_affiliation_strings":["Department of Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048300954","display_name":"Moussab Damlaj","orcid":"https://orcid.org/0000-0001-8326-2193","observed_orcids":["https://orcid.org/0000-0001-8326-2193","https://orcid.org/0009-0008-3591-6322"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moussab Damlaj","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hassan B Alkhateeb","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006752272","display_name":"Raymund Rabe Razonable","orcid":"https://orcid.org/0000-0001-5248-0227","observed_orcids":["https://orcid.org/0000-0001-5248-0227"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raymund Razonable","raw_affiliation_strings":["Department of Infectious Disease, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Disease, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aref Al-Kali","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043033429","display_name":"Shahrukh Khurshid Hashmi","orcid":"https://orcid.org/0000-0002-8914-7927","observed_orcids":["https://orcid.org/0000-0002-8914-7927"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahrukh K. Hashmi","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084606047","display_name":"William J. Hogan","orcid":"https://orcid.org/0000-0002-5841-4105","observed_orcids":["https://orcid.org/0000-0002-5841-4105"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J Hogan","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R Litzow","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M Patnaik","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006752272","https://openalex.org/A5064856519","https://openalex.org/A5067492340"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30450739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"1913","last_page":"1913"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.5356000065803528,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.5356000065803528,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.44999998807907104,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytomegalovirus-infection","display_name":"cytomegalovirus infection","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.9330000281333923},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.9990000128746033},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.7379999756813049},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.9599999785423279},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8799999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8840000033378601},{"id":"https://openalex.org/keywords/allogeneic-transplantation","display_name":"allogeneic transplantation","score":0.671999990940094},{"id":"https://openalex.org/keywords/t-cell-replete-grafts","display_name":"T-cell replete graft","score":0.7990000247955322},{"id":"https://openalex.org/keywords/post-transplant-viral-infection","display_name":"post-transplant viral infection","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7318934202194214},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6215599775314331},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6205658912658691},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.6095213890075684},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4928905963897705},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.43770310282707214},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42445603013038635},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4217197299003601},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4091717004776001},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3412719964981079},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1913.1913","doi":"https://doi.org/10.1182/blood.v126.23.1913.1913","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1913.1913","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2337260561","https://openalex.org/W2913978535","https://openalex.org/W4389030915","https://openalex.org/W7117327564","https://openalex.org/W2043006352","https://openalex.org/W3119901887","https://openalex.org/W4400448794","https://openalex.org/W2000653963","https://openalex.org/W4205640695","https://openalex.org/W2908558379"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2],"impact":[3,35,95,576],"of":[4,11,69,85,96,217,260,307,352,451,459,517,522,537,582],"cytomegalovirus":[5],"(CMV)":[6],"infection":[7,154,333,359,427,466,484,543,555,601],"on":[8,103,577],"the":[9,67,83,94,166,207,252,286,326,350,364,457,479,570,580,588],"risk":[10,25,44,536],"relapse":[12,43,218,336,432,469,538,584],"after":[13,446],"Hematopoietic":[14],"Cell":[15],"Transplantation":[16],"(HCT)":[17],"remains":[18],"controversial,":[19],"with":[20,82,108,125,189,212,356,487,540,561,605],"some":[21],"studies":[22,70],"demonstrating":[23,33],"lower":[24,42,378,492,535,583],"(Green":[26],"et":[27,37,50,61],"al,":[28,38,51,62],"Blood":[29,39],"2013),":[30,40],"while":[31,77],"others":[32],"no":[34,361,506,575,615,637,649],"(Schmidt-Hieber":[36],"or":[41,54,116,199],"only":[45],"in":[46,55,282,325,337,363,382,393,411,418,429,433,437,442,499,508,556,569],"myeloablative":[47],"(MA)":[48],"(Manjappa":[49],"BBMT,":[52],"2014)":[53,64],"reduced":[56],"intensity":[57],"conditioning":[58],"(RIC)":[59],"(Cichocki":[60],"ASH":[63],"HCT.":[65,118,171,552],"Furthermore,":[66],"majority":[68],"have":[71],"used":[72,410],"antigenemia":[73],"for":[74,106,232],"CMV":[75,97,153,160,192,312,332,358,426,465,483,542,554,600,606,610,647],"monitoring,":[76],"there":[78,573],"is":[79,559,574,585],"limited":[80],"data":[81],"use":[84],"Quantitative":[86],"Nucleic":[87],"Acid":[88],"Testing":[89],"(QNAT).":[90],"Aim":[91],"To":[92],"determine":[93],"infection,":[98,193,313],"as":[99,157,223,579],"detected":[100,544],"by":[101,114,162,545,587],"QNAT,":[102],"transplant-related":[104],"outcomes":[105],"patients":[107,188,355,445,524],"acute":[109],"myeloid":[110],"leukemia":[111],"(AML),":[112],"stratified":[113,195],"MA":[115,198,267,288,327,353,551,557,682],"RIC":[117,271,398,460,480,571,689],"Methods":[119],"After":[120,302],"IRB":[121],"approval,":[122],"consecutive":[123,262],"adults":[124],"AML":[126,523],"who":[127,525],"underwent":[128,526],"allogenic":[129],"HCT":[130,272,289,399,531,558],"from":[131],"HLA-matched":[132,529],"peripheral":[133],"blood":[134],"(PB)":[135],"grafts":[136,148],"at":[137,237,698],"our":[138],"institution":[139],"between":[140,187],"2006":[141],"and":[142,181,190,194,202,210,219,241,251,254,268,277,320,334,344,376,380,385,414,440,467,473,496,502,510,564,595],"2014":[143],"were":[144,149,185,204,221,244,273],"retrospectively":[145],"reviewed.":[146],"All":[147,602],"T-cell":[150],"replete.":[151],"Early":[152,553],"was":[155,340,409,470,485],"defined":[156],"any":[158],"positive":[159],"result":[161],"PCR":[163],"assay":[164],"during":[165],"first":[167],"100":[168],"days":[169],"post":[170],"Relapse":[172],"incidence":[173,216],"(RI),":[174],"non-relapse":[175],"mortality":[176],"(NRM),":[177],"disease-free":[178],"survival":[179,183,578],"(DFS),":[180],"overall":[182],"(OS)":[184],"compared":[186,211],"without":[191,609],"according":[196,598],"to":[197,331,335,464,468,599],"RIC.":[200],"DFS":[201,379,509],"OS":[203,381,511],"estimated":[205],"using":[206,226,246],"Kaplan-Meier":[208],"method,":[209],"log-rank":[213],"test.":[214,228],"Cumulative":[215],"NRM":[220,319,375,436,498,563],"analyzed":[222],"competing":[224],"events,":[225],"Gray's":[227],"Multivariable":[229],"analyses":[230],"adjusting":[231],"patient's":[233],"age,":[234,625],"disease":[235,594],"status":[236,697],"transplant,":[238],"cytogenetic":[239],"risk,":[240],"ABO":[242],"incompatibility":[243],"performed":[245],"Cox's":[247],"proportional":[248],"hazards":[249],"regression,":[250],"Fine":[253],"Gray":[255],"approach.":[256],"Results":[257],"A":[258],"total":[259,299],"190":[261,617],"patients,":[263],"including":[264],"94":[265,287,690],"(49%)":[266],"96":[269,397,683],"(51%)":[270],"analyzed.":[274],"Patients,":[275,593,614,636],"disease,":[276],"transplant":[278,596],"characteristics":[279,597],"are":[280],"shown":[281,392],"table":[283,394],"1.":[284,592],"Of":[285],"(median":[290,400],"age":[291,401],"45":[292],"y,":[293,403],"50%":[294],"male),":[295,405],"66":[296],"(70%)":[297],"received":[298],"body":[300],"irradiation.":[301],"a":[303,370,447,488,518,527,533],"median":[304,448,462],"follow":[305,449],"up":[306,450],"18":[308],"m,":[309],"36":[310,692],"(38%)":[311],"16":[314],"(17%)":[315],"relapses,":[316],"22":[317],"(23%)":[318],"35":[321,662],"(37%)":[322],"deaths":[323,441],"occurred":[324,428],"group.":[328],"Median":[329,624],"time":[330,463],"this":[338,423],"group":[339,521],"38":[341],"(range":[342],"8-241)":[343],"140":[345],"(29-1690)":[346],"days,":[347,476],"respectively.":[348,477],"Among":[349,396,456],"recipients":[351,458],"HCT,":[354,461,572],"early":[357,425,482,541],"showed":[360],"difference":[362,507],"RI":[365,493],"(figure":[366,388,494,512],"1),":[367],"but":[368,505,549],"had":[369],"significant":[371,489],"trend":[372,490],"towards":[373,491],"higher":[374,497,562,589],"significantly":[377,534],"both":[383,500],"univariate":[384],"multivariable":[386,503],"analysis":[387],"2)":[389],"(P":[390],"values":[391],"2).":[395,513],"59":[402],"56%":[404],"fludarabine":[406,415],"plus":[407,416],"melphalan":[408],"62":[412],"(65%)":[413],"busulfan":[417],"34":[419,709],"(35%)":[420],"patients.":[421],"In":[422,478],"group,":[424,481],"33":[430,685],"(34%),":[431],"25":[434,438],"(26%),":[435,439],"46":[443,704,734],"(48%)":[444],"21":[452,713,741],"m":[453],"(1-91":[454],"m).":[455],"40":[471],"(17-175)":[472],"291":[474],"(19-1971)":[475],"associated":[486,539,560],"1)":[495],"univariable":[501],"analysis,":[504],"Conclusion":[514],"Our":[515],"study":[516],"large":[519],"homogenous":[520],"uniform":[528],"PB":[530],"demonstrates":[532],"QNAT":[546],"following":[547],"RIC,":[548],"not":[550],"therefore":[565],"inferior":[566],"survival,":[567],"whereas":[568],"benefit":[581],"offset":[586],"NRM.":[590],"Table":[591],"Patients":[603,604,608],"Viremia":[607,611],"P":[612],"value":[613],"(%)":[616,638,650],"(100)":[618],"69":[619],"(36)":[620],"121":[621],"(64)":[622],"-":[623],"y":[626],"(range)":[627],"54":[628,630,632],"(18-72)":[629,633],"(26-70)":[631],"0.75":[634],"Male":[635],"104":[639],"(55)":[640],"30":[641],"(43)":[642,679],"74":[643],"(61)":[644],"0.02":[645],"D/R":[646],"Serostatus,":[648],"<0.0001":[651],"-/-":[652],"29":[653,664],"(15)":[654],"1":[655,669],"(1)":[656,670],"28":[657],"(23)":[658],"+/+":[659],"64":[660],"(34)":[661],"(51)":[663,684],"(24)":[665],"+/-":[666],"13":[667,711],"(7)":[668],"12":[671],"(10)":[672],"-/+":[673],"84":[674,736],"(44)":[675],"32":[676],"(47)":[677],"52":[678,739],"Conditioning":[680],"0.65":[681,723],"(48)":[686,695],"63":[687],"(52)":[688,693],"(49)":[691],"58":[694],"Disease":[696],"Transplant":[699],"0.96":[700],"CR1":[701],"129":[702],"(68)":[703,733],"(67)":[705,735],"83":[706],"(69)":[707,737],"CR2":[708],"(18)":[710],"(19)":[712],"(17)":[714],"Other":[715],"27":[716],"(14)":[717,719,721],"10":[718],"17":[720],"Cytogenetic":[722],"Favorable":[724],"8":[725],"(4)":[726],"2":[727],"(3)":[728],"6":[729],"(5)":[730],"Intermediate":[731],"130":[732],"Unfavorable":[738],"(28)":[740],"(30)":[742],"31":[743],"(26)":[744],"Disclosures":[745],"Al-Kali:":[746],"Novartis:":[747],"Research":[748],"Funding.":[749]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2017-03-03T00:00:00"}